Type2 Diabetes Clinical Trials

11 recruiting

Type2 Diabetes Trials at a Glance

17 actively recruiting trials for type2 diabetes are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Baglan, Bangkok, and Beijing. Lead sponsors running type2 diabetes studies include Beijing Friendship Hospital, Charite University, Berlin, Germany, and Alexandra Kautzky-Willer.

Browse type2 diabetes trials by phase

Treatments under study

About Type2 Diabetes Clinical Trials

Looking for clinical trials for Type2 Diabetes? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Type2 Diabetes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Type2 Diabetes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Not Applicable

SnapDandCGMinType2Diabetes

Type2 Diabetes Mellitus
Ramathibodi Hospital45 enrolled1 locationNCT07533604
Recruiting
Early Phase 1

SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Heart Failure With Preserved Ejection FractionType2 Diabetes
The University of Texas Health Science Center at San Antonio30 enrolled1 locationNCT05057806
Recruiting
Not Applicable

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

Type2 Diabetes Mellitus
NovoBliss Research Pvt Ltd14 enrolled1 locationNCT06961019
Recruiting

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

Peripheral NeuropathyType2 Diabetes
Zabeen Mahuwala, MD40 enrolled2 locationsNCT03481283
Recruiting

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Insulin ResistanceCognitive DeclineInflammation+8 more
Washington University School of Medicine117 enrolled2 locationsNCT05277558
Recruiting

UK Imaging Diabetes Study Seeing Diabetes Clearly

Type2 Diabetes
Perspectum1,000 enrolled12 locationsNCT05057403
Recruiting
Not Applicable

Small Bowel Diversion

ObesityType2 Diabetes
University of Ostrava80 enrolled2 locationsNCT06374368
Recruiting

Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico

ObesityCardiovascular DiseasesMetabolic Syndrome+13 more
Harvard School of Public Health (HSPH)2,000 enrolled1 locationNCT03794531
Recruiting
Phase 4

The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients

Type2 Diabetes With Depressive Mood
Yonsei University60 enrolled1 locationNCT03059069
Recruiting
Phase 4

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital100 enrolled1 locationNCT06449833
Recruiting
Phase 3

Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus
Tanta University46 enrolled1 locationNCT06430125
Recruiting
Not Applicable

NAFLD Primary Care

Cardiovascular DiseasesMetabolic SyndromeNon-Alcoholic Fatty Liver Disease+2 more
Maastricht University1,470 enrolled1 locationNCT04918732
Recruiting
Not Applicable

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins

NAFLDType2 Diabetes
Charite University, Berlin, Germany80 enrolled1 locationNCT04564391
Recruiting
Phase 4

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Hypogonadism, MaleFatty LiverOverweight/Obesity+1 more
Alexandra Kautzky-Willer32 enrolled1 locationNCT03851627
Recruiting
Not Applicable

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Type2 DiabetesComplication of Bariatric Procedure
Beijing Friendship Hospital248 enrolled1 locationNCT05015283
Recruiting
Not Applicable

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

Gestational DiabetesType2 DiabetesPregnancy in Diabetic
The University of Texas Health Science Center, Houston200 enrolled1 locationNCT04206748
Recruiting
Not Applicable

STOP DIABETES - Knowledge-based Solutions

Physical ActivityDiet HabitLife Style+2 more
University of Eastern Finland10,000 enrolled1 locationNCT03156478